SCHEMBL23633280

SCHEMBL23633280

COc1ccc(/C=C2/CC/C(=C/c3ccc(OC)cc3)C2=O)cc1

nearest known ligand 0.86

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.86
EGFR P00533 6/20 0.73
XDH P47989 2/20 0.63
MAPT P10636 3/20 0.63
DYRK1A Q13627 2/20 0.63
DYRK1B Q9Y463 2/20 0.63
MIF P14174 3/20 0.62
TDP1 Q9NUW8 2/20 0.62
GAA P10253 2/20 0.62
PLIN1 O60240 1/20 0.62
LMNA P02545 1/20 0.62
MAPK1 P28482 1/20 0.62
PLIN5 Q00G26 1/20 0.62
ABHD5 Q8WTS1 1/20 0.62
NCOA3 Q9Y6Q9 1/20 0.62
MEN1 O00255 2/20 0.61
ALDH1A1 P00352 2/20 0.61
KMT2A Q03164 2/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
CYP26A1 O43174 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17693071 1.00 CYP1A2 (0.86) CYP1A2EGFRXDHMAPTDYRK1A
SCHEMBL17693074 0.93 CYP1A2 (1.00) CYP1A2EGFRXDHMAPTDYRK1A
SCHEMBL17077381 0.92 EGFR (0.88) CYP1A2EGFRXDHNFE2L2
SCHEMBL17077379 0.92 EGFR (0.88) CYP1A2EGFRXDHNFE2L2
SCHEMBL1524473 0.88 CYP1A2 (0.69) CYP1A2EGFRXDHMAPTDYRK1A
SCHEMBL1524472 0.88 CYP1A2 (0.69) CYP1A2EGFRXDHMAPTDYRK1A
SCHEMBL17691416 0.87 CYP1A2 (0.68) CYP1A2EGFRXDHMAPTDYRK1A
SCHEMBL18513420 0.87 CYP1A2 (0.88) CYP1A2EGFRXDHMAPTDYRK1A
SCHEMBL15940309 0.85 CYP1A2 (0.69) CYP1A2EGFRXDHMAPTDYRK1A
SCHEMBL15940308 0.85 CYP1A2 (0.69) CYP1A2EGFRXDHMAPTDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210309617-A1 INHIBITION OF RESPIRATORY COMPLEX III BY LIGANDS THAT INTERACT WITH A REGULATORY SWITCH THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-10-07 US disclosed
US-11058645-B2 Inhibition of respiratory complex III by ligands that interact with a regulatory switch THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210309617-A1 INHIBITION OF RESPIRATORY COMPLEX III BY LIGANDS THAT INTERACT WITH A REGULATORY SWITCH MT-CO3, NDUFV3, MT-ND3 CYP1A2 2181/4885EGFR 2876/4885XDH 709/4885
US-11058645-B2 Inhibition of respiratory complex III by ligands that interact with a regulatory switch MT-CO3, NDUFV3, MT-ND3 CYP1A2 2181/4885EGFR 2876/4885XDH 709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.